Search results for "Pain threshold"

showing 10 items of 79 documents

Brain processing during mechanical hyperalgesia in complex regional pain syndrome: a functional MRI study.

2005

Complex Regional Pain Syndromes (CRPS) are characterized by a triad of sensory, motor and autonomic dysfunctions of still unknown origin. Pain and mechanical hyperalgesia are hallmarks of CRPS. There are several lines of evidence that central nervous system (CNS) changes are crucial for the development and maintenance of mechanical hyperalgesia. However, little is known about the cortical structures associated with the processing of hyperalgesia in pain patients. This study describes the use of functional magnetic resonance imaging (fMRI) to delineate brain activations during pin-prick hyperalgesia in CRPS. Twelve patients, in whom previous quantitative sensory testing revealed the presence…

Cingulate cortexAdultMalePain ThresholdSensory systemSomatosensory systemThreshold of painmedicineHumansAnterior cingulate cortexBrainMiddle Agedmedicine.diseaseMagnetic Resonance ImagingAnesthesiology and Pain MedicineNociceptionmedicine.anatomical_structureComplex regional pain syndromeNeurologyHyperalgesiaTouchHyperalgesiaFemaleNeurology (clinical)medicine.symptomPsychologyNeuroscienceComplex Regional Pain SyndromesPain
researchProduct

Effectiveness of Self-Hypnosis on the Relief of Experimental Dental Pain: A Randomized Trial.

2016

This randomized, controlled clinical trial evaluates the effectiveness of self-hypnosis on pain perception. Pain thresholds were measured, and a targeted, standardized pain stimulus was created by electrical stimulation of the dental pulp of an upper anterior tooth. Pain stimulus was rated by a visual analogue scale (VAS). The pain threshold under self-hypnosis was higher (57.1 ± 17.1) than without hypnotic intervention (39.5 ± 11.8) (p < .001). Pain was rated lower on the VAS with self-hypnosis (4.0 ± 3.8) than in the basal condition without self-hypnosis (7.1 ± 2.7) (p < .001). Self-hypnosis can be used in clinical practice as an adjunct to the gold standard of local anesthesia for pain m…

Complementary and Manual TherapyAdultMalePain ThresholdHypnosismedicine.medical_specialtyHypnosis DentalVisual analogue scalePainlaw.invention03 medical and health sciencesYoung Adult0302 clinical medicineRandomized controlled triallawSelf-hypnosisThreshold of painMedicineHumansLocal anesthesiaDental CarePain Measurementbusiness.industry030206 dentistryMiddle AgedClinical trialPain stimulusClinical PsychologyAnesthesiaPhysical therapyFemalebusiness030217 neurology & neurosurgeryThe International journal of clinical and experimental hypnosis
researchProduct

Digestive vacuole of Plasmodium falciparum released during erythrocyte rupture dually activates complement and coagulation.

2012

Abstract Severe Plasmodium falciparum malaria evolves through the interplay among capillary sequestration of parasitized erythrocytes, deregulated inflammatory responses, and hemostasis dysfunction. After rupture, each parasitized erythrocyte releases not only infective merozoites, but also the digestive vacuole (DV), a membrane-bounded organelle containing the malaria pigment hemozoin. In the present study, we report that the intact organelle, but not isolated hemozoin, dually activates the alternative complement and the intrinsic clotting pathway. Procoagulant activity is destroyed by phospholipase C treatment, indicating a critical role of phospholipid head groups exposed at the DV surfa…

HemeproteinsMalePain ThresholdErythrocytesImmunologyComplement Pathway AlternativePlasmodium falciparumVacuoleBiochemistryHemolysisMonocytesMicrobiologyHypesthesiaRats Sprague-DawleyPhagocytosisparasitic diseasesAnimalsHumansMalaria FalciparumBlood CoagulationLungbiologyPhospholipase CHemozoinDextran SulfatePlasmodium falciparumCell BiologyHematologyIntracellular Membranesbiology.organism_classificationComplement systemRatsAntibody opsonizationImmunologyVacuolesAlternative complement pathwaySpleenWaste disposalBlood
researchProduct

Understanding Cannabinoid Psychoactivity with Mouse Genetic Models

2007

Marijuana and its main psychotropic ingredient Δ9-tetrahydrocannabinol (THC) exert a plethora of psychoactive effects through the activation of the neuronal cannabinoid receptor type 1 (CB1), which is expressed by different neuronal subpopulations in the central nervous system. The exact neuroanatomical substrates underlying each effect of THC are, however, not known. We tested locomotor, hypothermic, analgesic, and cataleptic effects of THC in conditional knockout mouse lines, which lack the expression of CB1 in different neuronal subpopulations, including principal brain neurons, GABAergic neurons (those that release γ aminobutyric acid), cortical glutamatergic neurons, and neurons expres…

MaleMESH: Body TemperatureCannabinoid receptormedicine.medical_treatmentGene ExpressionMESH: Receptor Cannabinoid CB1NeocortexMESH: gamma-Aminobutyric AcidMESH: CatalepsyPharmacologyHippocampusMESH: Mice KnockoutMESH: Corpus StriatumBody TemperatureMESH: Autonomic Nervous SystemMESH: NeocortexMice0302 clinical medicineReceptor Cannabinoid CB1MESH: Behavior AnimalCannabinoid receptor type 1MESH: AnimalsMESH: Gene SilencingDronabinolMESH: NociceptorsBiology (General)gamma-Aminobutyric AcidMice Knockout0303 health sciencesBehavior Animalmusculoskeletal neural and ocular physiologyGeneral NeuroscienceMESH: Pain ThresholdNociceptorsMESH: Glutamic AcidMESH: InterneuronsMESH: Motor Activity3. Good healthGABAergicMESH: TetrahydrocannabinolGeneral Agricultural and Biological SciencesResearch Articlemedicine.drugPain ThresholdMESH: Gene ExpressionMESH: Psychotropic DrugsQH301-705.5Glutamic AcidMotor ActivityBiologyAutonomic Nervous SystemGeneral Biochemistry Genetics and Molecular Biologygamma-Aminobutyric acid03 medical and health sciencesGlutamatergicDopamine receptor D1InterneuronsCannabinoid Receptor Modulatorsmental disorders[SDV.BBM] Life Sciences [q-bio]/Biochemistry Molecular BiologymedicineAnimalsGenetic Predisposition to Disease[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular BiologyGene SilencingTetrahydrocannabinolMESH: MiceAnesthesiology and Pain Management030304 developmental biologyPharmacologyCatalepsyPsychotropic DrugsModels GeneticGeneral Immunology and MicrobiologyCannabinoidsIllicit Drugsorganic chemicalsMESH: MaleCorpus StriatumPrimerDisease Models Animalnervous systemCannabinoidNervous System Diseases030217 neurology & neurosurgeryNeurosciencePLoS Biology
researchProduct

The gamma(2)-MSH peptide mediates a central analgesic effect via a GABA-ergic mechanism that is independent from activation of melanocortin receptors.

2001

Using the latency for tail-flick after thermal stimulation we have assessed the effects of alpha-, gamma(1)- and gamma(2)-MSH on nociceptive threshold in the mice. Intracisternal injections of gamma(2)-MSH induced a distinct analgesia, while gamma(1)-MSH in the same doses gave only a minor analgesia. Intracisternal alpha-MSH instead gave a short-term hyperalgesia. The effect of gamma(2)-MSH was not blocked by any of the MC(4)/MC(3)receptor antagonist HS014, naloxone or by the prior intracisternal administrations of gamma(1)-MSH. However, the gamma(2)-MSH analgesic response was completely attenuated by treating animals with the GABA(A)antagonist bicuculline. The gamma(2)-MSH analgesic effect…

MaleNarcotic Antagonists(+)-NaloxonePharmacologyGABA Antagonistschemistry.chemical_compoundMiceEndocrinologyDrug Interactionsgamma-Aminobutyric AcidAnalgesicsMice Inbred BALB Cintegumentary systemMuscimolNaloxoneReceptors MelanocortinNociceptorsGeneral MedicineReceptor antagonistNeurologyHyperalgesiamedicine.symptomhormones hormone substitutes and hormone antagonistsmedicine.drugPain ThresholdTailendocrine systemmedicine.medical_specialtyanimal structuresmedicine.drug_classCatalepsyBicucullinePeptides CyclicCellular and Molecular Neurosciencegamma-MSHMelanocortin receptorInternal medicinemedicineAnimalsGABA ModulatorsGABA AgonistsCatalepsyDiazepamEthanolEndocrine and Autonomic SystemsAntagonistCentral Nervous System DepressantsBicucullinemedicine.diseaseEndocrinologyMuscimolchemistryReceptors Corticotropinalpha-MSHNeuropeptides
researchProduct

Effects of 7-OH-DPAT and U 99194 on the behavioral response to hot plate test, in rats

2005

Aim of present study was to investigate in male Wistar rats, whether behavioral response to hot plate test application could be influenced by systemic administration of 7-OH-DPAT, a dopaminergic (DA) D3 versus D2 receptor agonist, or U 99194, a DA D3 versus D2 receptor antagonist. Each trial lasted no more than 10 s and the whole experimental session lasted 120 min. Animal behavior was recorded by means of a digital videocamera and later, frame by frame examined using a professional videorecorder. Latency of each behavioral pattern, characterizing the response, was analysed, showing significant changes only with U 99194. A multivariate cluster analysis indicated the presence of three main b…

MalePain ThresholdAgonistmedicine.medical_specialtyHot TemperatureDopaminergic D3 receptorTetrahydronaphthalenesmedicine.drug_classDopamine AgentsExperimental and Cognitive Psychology7-OH-DPATSettore BIO/09 - FisiologiaBehavioral Neurosciencechemistry.chemical_compoundDopamine receptor D3Dopamine receptor D2Internal medicineAvoidance LearningReaction TimemedicineAnimalsCluster AnalysisRats WistarHot plate testNeurotransmitterBehavioral switching7-OH-DPATStochastic ProcessesBehavior AnimalReceptors Dopamine D2U 99194DopaminergicBehavioral patternRatsEndocrinologychemistryIndansRatPsychologyLearning processePhysiology &amp; Behavior
researchProduct

Effects of acute and chronic maprotiline administration on inhibitory avoidance in male mice

2000

The effects of acute and chronic administration of maprotiline (5, 10 or 20 mg/kg, intraperitoneally) were assessed on inhibitory avoidance in male mice. Acute administration of maprotiline before training did not effect training phase latencies, but impaired performance (i.e. produced shorter latencies) in the test at doses of 5 and 20 mg/kg. When given after training, the drug did not modify test latencies at any of the doses used. Chronic administration for 21 days (interrupted 24 h before training) also shortened latencies in the test but not in training. An experiment on the acute effects of maprotiline on analgesia (determination of flinch and jump thresholds for increasing electric f…

MalePain ThresholdAnterograde amnesiaRatónInhibitory postsynaptic potentialDrug Administration ScheduleDevelopmental psychologyNorepinephrine (medication)MiceBehavioral NeuroscienceDrug toleranceThreshold of painAvoidance LearningReaction TimemedicineAnimalsMaprotilineDose-Response Relationship DrugBrainNeural InhibitionDrug ToleranceMaprotilineAnesthesiaMental RecallAntidepressive Agents Second-Generationmedicine.symptomPsychologyReuptake inhibitorInjections Intraperitonealmedicine.drugBehavioural Brain Research
researchProduct

Depressive-like symptoms in a reserpine-induced model of fibromyalgia in rats.

2015

Since the pathogenesis of fibromyalgia is unknown, treatment options are limited, ineffective and in fact based on symptom relief. A recently proposed rat model of fibromyalgia is based on central depletion of monamines caused by reserpine administration. This model showed widespread musculoskeletal pain and depressive-like symptoms, but the methodology used to measure such symptoms has been criticized. Evidence relates the high prevalence of pain and depression in fibromyalgia to common pathogenic pathways, most probably focused on the monoaminergic system. The present study aims at a validation of the reserpine model of fibromyalgia. For this purpose, rats undergoing this model have been …

MalePain ThresholdFood deprivationmedicine.medical_specialtyFibromyalgiaReserpineTime FactorsPhysiologyExperimental and Cognitive PsychologyMotor ActivityOpen fieldRats Sprague-DawleyBehavioral NeuroscienceAnimal modelFibromyalgiaMonoaminergicMedicineAnimalsDepression (differential diagnoses)Adrenergic Uptake Inhibitorsbusiness.industryDepressionFeeding BehaviorReserpinemedicine.diseaseTest adaptationRatsDisease Models AnimalInhibition PsychologicalHindlimb SuspensionPhysical therapyExploratory Behaviorbusinessmedicine.drugPhysiologybehavior
researchProduct

Pharmacological Screening of DifferentJuniperus oxycedrusL. Extracts

1998

Methanol and dichloromethanol extracts of leaves and stems of Juniperus oxycedrus have been tested for their toxicity, analgesic, antiinflammatory and central effects. Both extracts showed low acute toxicity and decreased spontaneous motility. The methanol extract exhibited an analgesic effect in models of chemical, mechanical and thermal stimulation whereas dichloromethanol extract showed only a significant effect in models of pain induced by chemical stimulation. Both extracts showed a significant antiinflammatory activity and inhibition of the rat paw oedema induced by carrageenin.

MalePain ThresholdHealth Toxicology and MutagenesisAnalgesicStimulationMotor ActivityPharmacognosyToxicologylaw.inventionMicelawAnimalsRats WistarInflammationPharmacologybiologyTraditional medicinePlant ExtractsChemistryMethanolBiological activitybiology.organism_classificationAcute toxicityRatsBiochemistryJuniperusToxicityFemaleJuniperus oxycedrusPhytotherapyPhytotherapyPharmacology &amp; Toxicology
researchProduct

Sensory neuropathy and signs of central sensitization in patients with peripheral arterial disease.

2006

Patients with peripheral arterial disease (PAD) may develop a broad range of peripheral nerve dysfunctions including pain and sensory deficiencies due to chronic ischemia mostly involving the lower limbs. To investigate the degree of sensory abnormalities in such patients quantitative sensory testing (QST) might be a useful tool. Forty-five patients and 20 controls were enrolled in the present study and underwent QST according to the protocol of the German Research Network on Neuropathic Pain. PAD was graded according to the Rutherford classification. PAD patients were divided into two groups: 16 patients with critical limb ischemia (severe PAD) and 29 patients with intermittent claudicatio…

MalePain ThresholdIschemiaSensationSensationmedicineHumansThermosensingAgedPain MeasurementNeurologic ExaminationPeripheral Vascular DiseasesAnalysis of Variancebusiness.industryPeripheral Nervous System DiseasesCritical limb ischemiamedicine.diseaseIntermittent claudicationbody regionsAnesthesiology and Pain MedicinePeripheral neuropathyAllodyniamedicine.anatomical_structureNeurologyAnesthesiaCase-Control StudiesNeuropathic painSensation DisordersFemaleNeurology (clinical)medicine.symptombusinessSensory nervePain
researchProduct